April 30, 2020
COVID-19 ethics and social issues webinar
Webinar – APPRISE researchers based at Sydney Health Ethics at the University of Sydney discuss many ethical and social issues related to response to the COVID-19 global pandemic.
APPRISE News
April 23, 2020
The COVID-19 treatment trials that ‘learn as they go’
Researchers at the Doherty Institute are leading a trial that steps up to unique challenges posed by the current pandemic: the Australasian COVID-19 Trial (ASCOT).
April 13, 2020
NHMRC gives $2m for COVID-19 research in areas of urgent need
The National Health and Medical Research Council (NHMRC) is giving an additional $2m of funding to APPRISE for COVID-19 research.
April 9, 2020
Guiding decisions about health resources during the COVID-19 pandemic
A new ethics framework aims to help clinicians and policy makers decide how to allocate scarce clinical resources during a pandemic such as COVID-19.
April 8, 2020
COVID-19 modelling papers and press conference
Researchers from Doherty Institute, APPRISE and elsewhere have released their COVID-19 modelling to the general public.
April 1, 2020
Models have supported Australia’s response to COVID-19
Models have supported Australia’s response to COVID-19 and are a vital part of moving from preparedness to targeted response.
March 25, 2020
APPRISED Issue 8 – March 2020
Latest newsletter from the APPRISE Centre of Research Excellence.
March 23, 2020
Paul Ramsay Foundation commits $2m to support APPRISE COVID-19 research with First Nations Peoples
The Paul Ramsay Foundation has generously committed $2 million in grant funding to the development of effective responses to COVID-19 for high-risk communities, particularly First Nations peoples.
March 19, 2020
Fast-tracked funding for the COVID-19 pandemic to support critical research areas
Urgent research projects in areas such as diagnostics, treatment and communication are among 16 new priority projects launched in response to COVID-19
March 17, 2020
COVID-19: the immune system can fight back
Melbourne researchers have mapped immune responses from one of Australia’s first novel coronavirus (COVID-19) patients, showing the body’s ability to fight the virus and recover from the infection.
